
American CryoStem Corporation
Aktie · US0253001046 (OTC)
Kein Kurs
n/a
Firmenprofil zu American CryoStem Corporation Aktie
American CryoStem Corporation develops, markets, and licenses adipose tissue derived technologies for use in the fields of Regenerative and Personalized Medicine. The company's products include CELLECT collection, transportation, and storage system, which is a solution for physicians to collect and deliver tissue samples; ATGRAFT adipose tissue storage service, a fat collection, processing, and storage solution that enables physicians to provide their patients with tissue products and cell storage options; and ATCELL adipose derived stem cells. It also offers ACSelerat cell culture media products for growing human stromal cells. In addition, the company, provides contract manufacturing services for Autokine-CM, an anti-aging topical formulation; and autologous skin care product line. American CryoStem Corporation was founded in 1987 and is based in Eatontown, New Jersey.
Unternehmensdaten
Name American CryoStem Corporation
Firma American CryoStem Corporation
Website
https://www.americancryostem.com
Heimatbörse
UTC
ISIN US0253001046
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO John S. Arnone
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,0 T
Adresse 1 Meridian Road, 07724 Eatontown
IPO Datum 2010-12-10
Ticker Symbole
| Name | Symbol |
|---|---|
| Over The Counter | CRYO |
Weitere Aktien
Investoren, die American CryoStem Corporation halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.



